secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pasithea Therapeutics Corp. (KTTA)
CIK:        0001841330
Form:       8-K/A
Filed at:   2022-06-27T23:59:59+00:00
Accession:  0001213900-22-035226
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.25
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pasithea amends 8-K to extend deadline for Alpha-5 Integrin financials filing
-----------------------------------------------------------------------------

- Original 8-K filed June 22, 2022 reported acquisition of Alpha-5 Integrin, LLC.
- This amendment confirms intent to file acquired company financials within 75 days from June 21, 2022.
- Pro forma financial information will also be filed within the same period.
- No other changes were made to the original Form 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1841330/000121390022035226/0001213900-22-035226-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1841330/000121390022035226/ea162141-8ka_pasithea.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-035226

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer